1. Home
  2. ALAR vs INTS Comparison

ALAR vs INTS Comparison

Compare ALAR & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

BUY

Current Price

$1.37

Market Cap

13.1M

Sector

Technology

ML Signal

BUY

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.30

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
INTS
Founded
2013
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
13.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ALAR
INTS
Price
$1.37
$3.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$16.00
★ $19.33
AVG Volume (30 Days)
★ 48.2K
21.1K
Earning Date
11-25-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.89
N/A
Revenue Next Year
$26.13
N/A
P/E Ratio
$44.31
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.16
$0.22
52 Week High
$16.56
$8.06

Technical Indicators

Market Signals
Indicator
ALAR
INTS
Relative Strength Index (RSI) 31.39 37.58
Support Level $1.16 $0.28
Resistance Level $2.10 $5.09
Average True Range (ATR) 0.13 0.33
MACD -0.03 -0.01
Stochastic Oscillator 15.25 16.21

Price Performance

Historical Comparison
ALAR
INTS

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: